47 results
F-1
NLSP
NLS Pharmaceutics Ltd
29 May 24
Registration statement (foreign)
7:38pm
therapies with high medical impact to address this critical and growing unmet need. Our dual development strategy is designed to optimize the outcome of our
424B5
NLSP
NLS Pharmaceutics Ltd
22 Mar 24
Prospectus supplement for primary offering
10:24am
of the next generation of CNS therapies with high medical impact to address this critical and growing unmet need. Our dual development strategy … unmet need. Our dual development strategy is designed to optimize the outcome of our clinical programs by developing new chemical entities from known
6-K
EX-99.2
NLSP
NLS Pharmaceutics Ltd
6 Dec 23
Unaudited Interim Condensed Financial Statements
4:44pm
total future research and development costs will increase over current levels in line with strategy to progress the development of our product
6-K
EX-99.1
qbpo6 mcs7lyn2770
4 Dec 23
Report of Foreign Private Issuer
4:00pm
6-K
EX-99.1
ojw3cwt37fy
13 Sep 23
Report of Foreign Private Issuer
4:03pm
6-K
EX-99.1
uspfa2c vd9baju
20 Jul 23
Report of Foreign Private Issuer
4:06pm
6-K
EX-99.2
eclbcyt agq
3 Jul 23
NLS Pharmaceutics Releases the Results from its Annual General Meeting
1:22pm
6-K
y0bpl05wtiupzvaj0t
8 May 23
NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer
8:30am
6-K
EX-99.1
vyhu814p6 tcb98
8 May 23
NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer
8:30am
6-K
EX-99.1
xfp8fj1xru2jp9i3 uh
22 Dec 22
NLS Pharmaceutics CEO Issues Letter to Shareholders
9:40am
F-3
1es vv3eul
6 Dec 22
Shelf registration (foreign)
4:41pm
6-K
EX-99.1
y0cfphf9aser2epka
11 Oct 22
Unaudited Interim Condensed Financial Statements
5:20pm
6-K
EX-99.2
z6ntbqsa
11 Oct 22
Unaudited Interim Condensed Financial Statements
5:20pm
F-1
zj47lr161r68uibd7k
10 Jun 22
Registration statement (foreign)
4:43pm
6-K
EX-99.1
0h6ca2o
6 Jun 22
NLS Pharmaceutics Appoints Chad C. Hellmann as Chief Financial Officer
8:02am
6-K
fqejjyj5883atxv
6 Jun 22
NLS Pharmaceutics Appoints Chad C. Hellmann as Chief Financial Officer
8:02am
424B5
8oq2hy370r4mo67p5nv
14 Apr 22
Prospectus supplement for primary offering
4:48pm